Tandem Diabetes Care (TNDM) Interest Expenses (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Interest Expenses came in at $170.0 million in Q1 2026, up 1708.84% YoY from $9.4 million in Q1 2025, and up 1083.4% on a QoQ basis from $14.4 million in Q4 2025.
Tandem Diabetes Care (TNDM) Interest Expenses (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Interest Expenses data on file, last reported at $170.0 million in Q1 2026.
- Quarterly Interest Expenses rose 1708.84% year-over-year to $170.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $170.0 million (up 1708.84% YoY) and the FY2025 annual result came in at $270.3 million, up 28.47% from the prior year.
- Interest Expenses grew to $170.0 million in Q1 2026, from $14.4 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $182.6 million in Q2 2025 to a low of $1.5 million in Q1 2023.
- A 5-year average of $28.1 million and a median of $9.4 million in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses sank 82.11% — and 2025, when it soared 1842.18%.
- Tracing TNDM's Interest Expenses over 5 years: stood at $30.2 million in 2022, then slumped by 80.75% to $5.8 million in 2023, then soared by 117.71% to $12.7 million in 2024, then climbed by 13.37% to $14.4 million in 2025, then soared by 1083.4% to $170.0 million in 2026.
- The last three Interest Expenses figures came in at $170.0 million (Q1 2026), $14.4 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 177.68 Mn |
| Jun 30, 2026 | 177.68 Mn |
| Mar 31, 2026 | 170.03 Mn |
| Mar 31, 2026 | 170.03 Mn |
| Dec 31, 2025 | 14.37 Mn |
| Dec 31, 2025 | 14.37 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Jun 30, 2025 | 182.57 Mn |
| Jun 30, 2025 | 182.57 Mn |
| Mar 31, 2025 | 9.40 Mn |
| Mar 31, 2025 | 9.40 Mn |
| Dec 31, 2024 | 12.67 Mn |
| Dec 31, 2024 | 12.67 Mn |
| Sep 30, 2024 | 9.40 Mn |
| Sep 30, 2024 | 9.40 Mn |
| Jun 30, 2024 | 9.40 Mn |
| Jun 30, 2024 | 9.40 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Mar 31, 2024 | 9.40 Mn |